The Emerging Hallmarks of Cancer Metabolism

Cell Metabolism

Volumn 23, Issue 1, 2016, Pages 27-47

  Pavlova, Natalya N ^a   Thompson, Craig B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLUCOSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; ANTINEOPLASTIC AGENT;

BIOSYNTHESIS; CANCER SURVIVAL; CARBON METABOLISM; CARCINOGENESIS; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; CELL VIABILITY; CITRIC ACID CYCLE; CLINICAL FEATURE; GENE CONTROL; GENE EXPRESSION; HUMAN; NEOPLASM; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; REVIEW; TUMOR CLASSIFICATION; TUMOR MICROENVIRONMENT; ANIMAL; CELL TRANSFORMATION; ENERGY METABOLISM; GENETICS; METABOLISM; MUTATION; NEOPLASMS; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CELL TRANSFORMATION, NEOPLASTIC; ENERGY METABOLISM; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MUTATION; NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84955326448     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2015.12.006     Document Type: Review

References (239)

1. A. Almuhaideb, N. Papathanasiou, and J. Bomanji 18F-FDG PET/CT imaging in oncology Ann. Saudi Med. 31 2011 3 13
2. D. Astuti, F. Latif, A. Dallol, P.L. Dahia, F. Douglas, E. George, F. Sköldberg, E.S. Husebye, C. Eng, and E.R. Maher Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma Am. J. Hum. Genet. 69 2001 49 54
3. J. Balss, J. Meyer, W. Mueller, A. Korshunov, C. Hartmann, and A. von Deimling Analysis of the IDH1 codon 132 mutation in brain tumors Acta Neuropathol. 116 2008 597 602
4. A. Barthel, S.T. Okino, J. Liao, K. Nakatani, J. Li, J.P. Whitlock Jr., and R.A. Roth Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1 J. Biol. Chem. 274 1999 20281 20286
5. D.E. Bauer, G. Hatzivassiliou, F. Zhao, C. Andreadis, and C.B. Thompson ATP citrate lyase is an important component of cell growth and transformation Oncogene 24 2005 6314 6322
6. I. Ben-Sahra, J.J. Howell, J.M. Asara, and B.D. Manning Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1 Science 339 2013 1323 1328
7. M.R. Benz, K. Herrmann, F. Walter, E.B. Garon, K.L. Reckamp, R. Figlin, M.E. Phelps, W.A. Weber, J. Czernin, and M.S. Allen-Auerbach (18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib J. Nucl. Med. 52 2011 1684 1689
8. J.A. Bertout, S.A. Patel, and M.C. Simon The impact of O2 availability on human cancer Nat. Rev. Cancer 8 2008 967 975
9. D.C. Berwick, I. Hers, K.J. Heesom, S.K. Moule, and J.M. Tavare The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes J. Biol. Chem. 277 2002 33895 33900
10. K. Birsoy, T. Wang, W.W. Chen, E. Freinkman, M. Abu-Remaileh, and D.M. Sabatini An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis Cell 162 2015 540 551
11. K. Blaschke, K.T. Ebata, M.M. Karimi, J.A. Zepeda-Martínez, P. Goyal, S. Mahapatra, A. Tam, D.J. Laird, M. Hirst, A. Rao, and et al. Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells Nature 500 2013 222 226
12. D.R. Borger, K.K. Tanabe, K.C. Fan, H.U. Lopez, V.R. Fantin, K.S. Straley, D.P. Schenkein, A.F. Hezel, M. Ancukiewicz, H.M. Liebman, and et al. Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping Oncologist 17 2012 72 79
13. T.L. Bowles, R. Kim, J. Galante, C.M. Parsons, S. Virudachalam, H.J. Kung, and R.J. Bold Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase Int. J. Cancer 123 2008 1950 1955
14. R.B. Boxer, D.B. Stairs, K.D. Dugan, K.L. Notarfrancesco, C.P. Portocarrero, B.A. Keister, G.K. Belka, H. Cho, J.C. Rathmell, C.B. Thompson, and et al. Isoform-specific requirement for Akt1 in the developmental regulation of cellular metabolism during lactation Cell Metab. 4 2006 475 490
15. P. Boya, F. Reggiori, and P. Codogno Emerging regulation and functions of autophagy Nat. Cell Biol. 15 2013 713 720
16. D.C. Brady, M.S. Crowe, M.L. Turski, G.A. Hobbs, X. Yao, A. Chaikuad, S. Knapp, K. Xiao, S.L. Campbell, D.J. Thiele, and C.M. Counter Copper is required for oncogenic BRAF signalling and tumorigenesis Nature 509 2014 492 496
17. K. Brand, W. Leibold, P. Luppa, C. Schoerner, and A. Schulz Metabolic alterations associated with proliferation of mitogen-activated lymphocytes and of lymphoblastoid cell lines: evaluation of glucose and glutamine metabolism Immunobiology 173 1986 23 34
18. L. Cai, B.M. Sutter, B. Li, and B.P. Tu Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes Mol. Cell 42 2011 426 437
19. B.W. Carey, L.W. Finley, J.R. Cross, C.D. Allis, and C.B. Thompson Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem cells Nature 518 2015 413 416
20. C. Carmona-Fontaine, V. Bucci, L. Akkari, M. Deforet, J.A. Joyce, and J.B. Xavier Emergence of spatial structure in the tumor microenvironment due to the Warburg effect Proc. Natl. Acad. Sci. USA 110 2013 19402 19407
21. R.A. Casero Jr., and L.J. Marton Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases Nat. Rev. Drug Discov. 6 2007 373 390
22. L.R. Cavalli, M. Varella-Garcia, and B.C. Liang Diminished tumorigenic phenotype after depletion of mitochondrial DNA Cell Growth Differ. 8 1997 1189 1198
23. V. Chajès, M. Cambot, K. Moreau, G.M. Lenoir, and V. Joulin Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival Cancer Res. 66 2006 5287 5294
24. J.W. Chambers, T.G. Maguire, and J.C. Alwine Glutamine metabolism is essential for human cytomegalovirus infection J. Virol. 84 2010 1867 1873
25. B. Chaneton, P. Hillmann, L. Zheng, A.C. Martin, O.D. Maddocks, A. Chokkathukalam, J.E. Coyle, A. Jankevics, F.P. Holding, K.H. Vousden, and et al. Serine is a natural ligand and allosteric activator of pyruvate kinase M2 Nature 491 2012 458 462
26. Y. Chen, R. Sprung, Y. Tang, H. Ball, B. Sangras, S.C. Kim, J.R. Falck, J. Peng, W. Gu, and Y. Zhao Lysine propionylation and butyrylation are novel post-translational modifications in histones Mol. Cell. Proteomics 6 2007 812 819
27. T. Cheng, J. Sudderth, C. Yang, A.R. Mullen, E.S. Jin, J.M. Matés, and R.J. DeBerardinis Pyruvate carboxylase is required for glutamine-independent growth of tumor cells Proc. Natl. Acad. Sci. USA 108 2011 8674 8679
28. E.P. Chiang, Y.C. Wang, W.W. Chen, and F.Y. Tang Effects of insulin and glucose on cellular metabolic fluxes in homocysteine transsulfuration, remethylation, S-adenosylmethionine synthesis, and global deoxyribonucleic acid methylation J. Clin. Endocrinol. Metab. 94 2009 1017 1025
29. C. Choi, S.K. Ganji, R.J. DeBerardinis, K.J. Hatanpaa, D. Rakheja, Z. Kovacs, X.L. Yang, T. Mashimo, J.M. Raisanen, I. Marin-Valencia, and et al. 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas Nat. Med. 18 2012 624 629
30. S.K. Chowdhury, A. Gemin, and G. Singh High activity of mitochondrial glycerophosphate dehydrogenase and glycerophosphate-dependent ROS production in prostate cancer cell lines Biochem. Biophys. Res. Commun. 333 2005 1139 1145
31. H.R. Christofk, M.G. Vander Heiden, M.H. Harris, A. Ramanathan, R.E. Gerszten, R. Wei, M.D. Fleming, S.L. Schreiber, and L.C. Cantley The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth Nature 452 2008 230 233
32. H.R. Christofk, M.G. Vander Heiden, N. Wu, J.M. Asara, and L.C. Cantley Pyruvate kinase M2 is a phosphotyrosine-binding protein Nature 452 2008 181 186
33. A.L. Cohen, S.L. Holmen, and H. Colman IDH1 and IDH2 mutations in gliomas Curr. Neurol. Neurosci. Rep. 13 2013 345
34. O.R. Colegio, N.Q. Chu, A.L. Szabo, T. Chu, A.M. Rhebergen, V. Jairam, N. Cyrus, C.E. Brokowski, S.C. Eisenbarth, G.M. Phillips, and et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid Nature 513 2014 559 563
35. C.L. Collins, M. Wasa, W.W. Souba, and S.F. Abcouwer Determinants of glutamine dependence and utilization by normal and tumor-derived breast cell lines J. Cell. Physiol. 176 1998 166 178
36. S.A. Comerford, Z. Huang, X. Du, Y. Wang, L. Cai, A.K. Witkiewicz, H. Walters, M.N. Tantawy, A. Fu, H.C. Manning, and et al. Acetate dependence of tumors Cell 159 2014 1591 1602
37. C. Commisso, S.M. Davidson, R.G. Soydaner-Azeloglu, S.J. Parker, J.J. Kamphorst, S. Hackett, E. Grabocka, M. Nofal, J.A. Drebin, C.B. Thompson, and et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells Nature 497 2013 633 637
38. M. Conrad, and H. Sato The oxidative stress-inducible cystine/glutamate antiporter, system x (c) (-): cystine supplier and beyond Amino Acids 42 2012 231 246
39. J.S. Constant, J.J. Feng, D.D. Zabel, H. Yuan, D.Y. Suh, H. Scheuenstuhl, T.K. Hunt, and M.Z. Hussain Lactate elicits vascular endothelial growth factor from macrophages: a possible alternative to hypoxia Wound Repair Regen. 8 2000 353 360
40. S. Courtois-Cox, S.L. Jones, and K. Cichowski Many roads lead to oncogene-induced senescence Oncogene 27 2008 2801 2809
41. J.T. Cunningham, M.V. Moreno, A. Lodi, S.M. Ronen, and D. Ruggero Protein and nucleotide biosynthesis are coupled by a single rate-limiting enzyme, PRPS2, to drive cancer Cell 157 2014 1088 1103
42. L. Dang, D.W. White, S. Gross, B.D. Bennett, M.A. Bittinger, E.M. Driggers, V.R. Fantin, H.G. Jang, S. Jin, M.C. Keenan, and et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature 465 2010 966
43. R.J. DeBerardinis, A. Mancuso, E. Daikhin, I. Nissim, M. Yudkoff, S. Wehrli, and C.B. Thompson Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis Proc. Natl. Acad. Sci. USA 104 2007 19345 19350
44. B. Delage, D.A. Fennell, L. Nicholson, I. McNeish, N.R. Lemoine, T. Crook, and P.W. Szlosarek Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer Int. J. Cancer 126 2010 2762 2772
45. J.M. Denu, and K.G. Tanner Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation Biochemistry 37 1998 5633 5642
46. J. Deprez, D. Vertommen, D.R. Alessi, L. Hue, and M.H. Rider Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades J. Biol. Chem. 272 1997 17269 17275
47. S.P. Donald, X.Y. Sun, C.A. Hu, J. Yu, J.M. Mei, D. Valle, and J.M. Phang Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species Cancer Res. 61 2001 1810 1815
48. Y.P. Du, J.S. Peng, A. Sun, Z.H. Tang, W.H. Ling, and H.L. Zhu Assessment of the effect of betaine on p16 and c-myc DNA methylation and mRNA expression in a chemical induced rat liver cancer model BMC Cancer 9 2009 261
49. R.V. Durán, W. Oppliger, A.M. Robitaille, L. Heiserich, R. Skendaj, E. Gottlieb, and M.N. Hall Glutaminolysis activates Rag-mTORC1 signaling Mol. Cell 47 2012 349 358
50. H. Eagle The minimum vitamin requirements of the L and HeLa cells in tissue culture, the production of specific vitamin deficiencies, and their cure J. Exp. Med. 102 1955 595 600
51. S.R. Eberhardy, and P.J. Farnham c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism J. Biol. Chem. 276 2001 48562 48571
52. C.M. Ensor, F.W. Holtsberg, J.S. Bomalaski, and M.A. Clark Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo Cancer Res. 62 2002 5443 5450
53. F. Fallarino, U. Grohmann, C. Vacca, R. Bianchi, C. Orabona, A. Spreca, M.C. Fioretti, and P. Puccetti T cell apoptosis by tryptophan catabolism Cell Death Differ. 9 2002 1069 1077
54. F. Fallarino, U. Grohmann, S. You, B.C. McGrath, D.R. Cavener, C. Vacca, C. Orabona, R. Bianchi, M.L. Belladonna, C. Volpi, and et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells J. Immunol. 176 2006 6752 6761
55. J. Fan, J. Ye, J.J. Kamphorst, T. Shlomi, C.B. Thompson, and J.D. Rabinowitz Quantitative flux analysis reveals folate-dependent NADPH production Nature 510 2014 298 302
56. M.E. Figueroa, O. Abdel-Wahab, C. Lu, P.S. Ward, J. Patel, A. Shih, Y. Li, N. Bhagwat, A. Vasanthakumar, H.F. Fernandez, and et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation Cancer Cell 18 2010 553 567
57. K. Fischer, P. Hoffmann, S. Voelkl, N. Meidenbauer, J. Ammer, M. Edinger, E. Gottfried, S. Schwarz, G. Rothe, S. Hoves, and et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells Blood 109 2007 3812 3819
58. R. Flavin, S. Peluso, P.L. Nguyen, and M. Loda Fatty acid synthase as a potential therapeutic target in cancer Future Oncol. 6 2010 551 562
59. L.J. Fontenelle, and J.F. Henderson Sources of nitrogen as rate-limiting factors for purine biosynthesis de novo in Ehrlich ascites tumor cells Biochim. Biophys. Acta 177 1969 88 93
60. W.A. Freed-Pastor, H. Mizuno, X. Zhao, A. Langerød, S.H. Moon, R. Rodriguez-Barrueco, A. Barsotti, A. Chicas, W. Li, A. Polotskaia, and et al. Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway Cell 148 2012 244 258
61. D. Gaglio, C. Soldati, M. Vanoni, L. Alberghina, and F. Chiaradonna Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts PLoS ONE 4 2009 e4715
62. P. Gao, I. Tchernyshyov, T.C. Chang, Y.S. Lee, K. Kita, T. Ochi, K.I. Zeller, A.M. De Marzo, J.E. Van Eyk, J.T. Mendell, and C.V. Dang c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism Nature 458 2009 762 765
63. W.S. Garrett Cancer and the microbiota Science 348 2015 80 86
64. E.W. Gerner, and F.L. Meyskens Jr. Polyamines and cancer: old molecules, new understanding Nat. Rev. Cancer 4 2004 781 792
65. K. Goetze, S. Walenta, M. Ksiazkiewicz, L.A. Kunz-Schughart, and W. Mueller-Klieser Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release Int. J. Oncol. 39 2011 453 463
66. E. Gottfried, L.A. Kunz-Schughart, S. Ebner, W. Mueller-Klieser, S. Hoves, R. Andreesen, A. Mackensen, and M. Kreutz Tumor-derived lactic acid modulates dendritic cell activation and antigen expression Blood 107 2006 2013 2021
67. K. Gottlob, N. Majewski, S. Kennedy, E. Kandel, R.B. Robey, and N. Hay Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase Genes Dev. 15 2001 1406 1418
68. A.R. Grassian, J.L. Coloff, and J.S. Brugge Extracellular matrix regulation of metabolism and implications for tumorigenesis Cold Spring Harb. Symp. Quant. Biol. 76 2011 313 324
69. L.M. Graves, H.I. Guy, P. Kozlowski, M. Huang, E. Lazarowski, R.M. Pope, M.A. Collins, E.N. Dahlstrand, H.S. Earp 3rd, and D.R. Evans Regulation of carbamoyl phosphate synthetase by MAP kinase Nature 403 2000 328 332
70. J.Y. Guo, G. Karsli-Uzunbas, R. Mathew, S.C. Aisner, J.J. Kamphorst, A.M. Strohecker, G. Chen, S. Price, W. Lu, X. Teng, and et al. Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis Genes Dev. 27 2013 1447 1461
71. A. Gupte, and R.J. Mumper Elevated copper and oxidative stress in cancer cells as a target for cancer treatment Cancer Treat. Rev. 35 2009 32 46
72. D. Hanahan, and L.M. Coussens Accessories to the crime: functions of cells recruited to the tumor microenvironment Cancer Cell 21 2012 309 322
73. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
74. J.M. Hill, J. Roberts, E. Loeb, A. Khan, A. MacLellan, and R.W. Hill L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia JAMA 202 1967 882 888
75. S. Hino, A. Sakamoto, K. Nagaoka, K. Anan, Y. Wang, S. Mimasu, T. Umehara, S. Yokoyama, K. Kosai, and M. Nakao FAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure Nat. Commun. 3 2012 758
76. M. Hirata, M. Sasaki, R.A. Cairns, S. Inoue, V. Puviindran, W.Y. Li, B.E. Snow, L.D. Jones, Q. Wei, S. Sato, and et al. Mutant IDH is sufficient to initiate enchondromatosis in mice Proc. Natl. Acad. Sci. USA 112 2015 2829 2834
77. S. Imai, C.M. Armstrong, M. Kaeberlein, and L. Guarente Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase Nature 403 2000 795 800
78. A.M. Intlekofer, R.G. Dematteo, S. Venneti, L.W. Finley, C. Lu, A.R. Judkins, A.S. Rustenburg, P.B. Grinaway, J.D. Chodera, J.R. Cross, and et al. Hypoxia induces production of L-2-hydroxyglutarate Cell Metab. 22 2015 304 311
79. H.M. Itkonen, S. Minner, I.J. Guldvik, M.J. Sandmann, M.C. Tsourlakis, V. Berge, A. Svindland, T. Schlomm, and I.G. Mills O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells Cancer Res. 73 2013 5277 5287
80. K.A. Janeway, S.Y. Kim, M. Lodish, V. Nosé, P. Rustin, J. Gaal, P.L. Dahia, B. Liegl, E.R. Ball, M. Raygada, et al. NIH Pediatric and Wild-Type GIST Clinic Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations Proc. Natl. Acad. Sci. USA 108 2011 314 318
81. J.L. Jewell, Y.C. Kim, R.C. Russell, F.X. Yu, H.W. Park, S.W. Plouffe, V.S. Tagliabracci, and K.L. Guan Metabolism. Differential regulation of mTORC1 by leucine and glutamine Science 347 2015 194 198
82. P. Jiang, W. Du, X. Wang, A. Mancuso, X. Gao, M. Wu, and X. Yang p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase Nat. Cell Biol. 13 2011 310 316
83. H. Kamata, S. Honda, S. Maeda, L. Chang, H. Hirata, and M. Karin Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases Cell 120 2005 649 661
84. J.J. Kamphorst, J.R. Cross, J. Fan, E. de Stanchina, R. Mathew, E.P. White, C.B. Thompson, and J.D. Rabinowitz Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids Proc. Natl. Acad. Sci. USA 110 2013 8882 8887
85. J.J. Kamphorst, M. Nofal, C. Commisso, S.R. Hackett, W. Lu, E. Grabocka, M.G. Vander Heiden, G. Miller, J.A. Drebin, D. Bar-Sagi, and et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein Cancer Res. 75 2015 544 553
86. J. Kaplon, L. Zheng, K. Meissl, B. Chaneton, V.A. Selivanov, G. Mackay, S.H. van der Burg, E.M. Verdegaal, M. Cascante, T. Shlomi, and et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence Nature 498 2013 109 112
87. S. Katada, A. Imhof, and P. Sassone-Corsi Connecting threads: epigenetics and metabolism Cell 148 2012 24 28
88. K.E. Keller, I.S. Tan, and Y.S. Lee SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions Science 338 2012 1069 1072
89. M.C. Kerr, and R.D. Teasdale Defining macropinocytosis Traffic 10 2009 364 371
90. J.K. Killian, S.Y. Kim, M. Miettinen, C. Smith, M. Merino, M. Tsokos, M. Quezado, W.I. Smith Jr., M.S. Jahromi, P. Xekouki, and et al. Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor Cancer Discov. 3 2013 648 657
91. J.W. Kim, I. Tchernyshyov, G.L. Semenza, and C.V. Dang HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia Cell Metab. 3 2006 177 185
92. M. Kollareddy, E. Dimitrova, K.C. Vallabhaneni, A. Chan, T. Le, K.M. Chauhan, Z.I. Carrero, G. Ramakrishnan, K. Watabe, Y. Haupt, and et al. Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities Nat. Commun. 6 2015 7389
93. M. Krajcovic, S. Krishna, L. Akkari, J.A. Joyce, and M. Overholtzer mTOR regulates phagosome and entotic vacuole fission Mol. Biol. Cell 24 2013 3736 3745
94. B.J. Krause, M. Souvatzoglou, and U. Treiber Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates Urol. Oncol. 31 2013 427 435
95. N.B. Kuemmerle, E. Rysman, P.S. Lombardo, A.J. Flanagan, B.C. Lipe, W.A. Wells, J.R. Pettus, H.M. Froehlich, V.A. Memoli, P.M. Morganelli, and et al. Lipoprotein lipase links dietary fat to solid tumor cell proliferation Mol. Cancer Ther. 10 2011 427 436
96. H.N. Kung, J.R. Marks, and J.T. Chi Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia PLoS Genet. 7 2011 e1002229
97. S.A. Kwee, T.R. DeGrado, J.N. Talbot, F. Gutman, and M.N. Coel Cancer imaging with fluorine-18-labeled choline derivatives Semin. Nucl. Med. 37 2007 420 428
98. V.S. LeBleu, J.T. O'Connell, K.N. Gonzalez Herrera, H. Wikman, K. Pantel, M.C. Haigis, F.M. de Carvalho, A. Damascena, L.T. Domingos Chinen, R.M. Rocha, and et al. PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis Nat. Cell Biol. 16 2014 992 1003 1001-1015
99. S.R. Lee, K.S. Yang, J. Kwon, C. Lee, W. Jeong, and S.G. Rhee Reversible inactivation of the tumor suppressor PTEN by H2O2 J. Biol. Chem. 277 2002 20336 20342
100. J.V. Lee, A. Carrer, S. Shah, N.W. Snyder, S. Wei, S. Venneti, A.J. Worth, Z.F. Yuan, H.W. Lim, S. Liu, and et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation Cell Metab. 20 2014 306 319
101. E. Letouzé, C. Martinelli, C. Loriot, N. Burnichon, N. Abermil, C. Ottolenghi, M. Janin, M. Menara, A.T. Nguyen, P. Benit, and et al. SDH mutations establish a hypermethylator phenotype in paraganglioma Cancer Cell 23 2013 739 752
102. S. Lheureux, C. Lecerf, M. Briand, M.H. Louis, S. Dutoit, A. Jebahi, F. Giffard, C.B. Fournier, A. Batalla, L. Poulain, and N. Aide (18)F-FDG is a surrogate marker of therapy response and tumor recovery after drug withdrawal during treatment with a dual PI3K/mTOR inhibitor in a preclinical model of cisplatin-resistant ovarian cancer Transl. Oncol. 6 2013 586 595
103. J. Li, and J.X. Cheng Direct visualization of de novo lipogenesis in single living cells Sci. Rep. 4 2014 6807
104. B.P. Lieberman, K. Ploessl, L. Wang, W. Qu, Z. Zha, D.R. Wise, L.A. Chodosh, G. Belka, C.B. Thompson, and H.F. Kung PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine J. Nucl. Med. 52 2011 1947 1955
105. T. Lindsten, J.A. Golden, W.X. Zong, J. Minarcik, M.H. Harris, and C.B. Thompson The proapoptotic activities of Bax and Bak limit the size of the neural stem cell pool J. Neurosci. 23 2003 11112 11119
106. Y.C. Liu, F. Li, J. Handler, C.R. Huang, Y. Xiang, N. Neretti, J.M. Sedivy, K.I. Zeller, and C.V. Dang Global regulation of nucleotide biosynthetic genes by c-Myc PLoS ONE 3 2008 e2722
107. Y. Liu, G.L. Borchert, S.P. Donald, B.A. Diwan, M. Anver, and J.M. Phang Proline oxidase functions as a mitochondrial tumor suppressor in human cancers Cancer Res. 69 2009 6414 6422
108. W. Liu, A. Le, C. Hancock, A.N. Lane, C.V. Dang, T.W. Fan, and J.M. Phang Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC Proc. Natl. Acad. Sci. USA 109 2012 8983 8988
109. M. Lo, Y.Z. Wang, and P.W. Gout The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases J. Cell. Physiol. 215 2008 593 602
110. J.W. Locasale, A.R. Grassian, T. Melman, C.A. Lyssiotis, K.R. Mattaini, A.J. Bass, G. Heffron, C.M. Metallo, T. Muranen, H. Sharfi, and et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis Nat. Genet. 43 2011 869 874
111. J.A. Losman, R.E. Looper, P. Koivunen, S. Lee, R.K. Schneider, C. McMahon, G.S. Cowley, D.E. Root, B.L. Ebert, and W.G. Kaelin Jr. (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible Science 339 2013 1621 1625
112. C. Lu, P.S. Ward, G.S. Kapoor, D. Rohle, S. Turcan, O. Abdel-Wahab, C.R. Edwards, R. Khanin, M.E. Figueroa, A. Melnick, and et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation Nature 483 2012 474 478
113. C. Lu, S. Venneti, A. Akalin, F. Fang, P.S. Ward, R.G. Dematteo, A.M. Intlekofer, C. Chen, J. Ye, M. Hameed, and et al. Induction of sarcomas by mutant IDH2 Genes Dev. 27 2013 1986 1998
114. J.J. Lum, D.E. Bauer, M. Kong, M.H. Harris, C. Li, T. Lindsten, and C.B. Thompson Growth factor regulation of autophagy and cell survival in the absence of apoptosis Cell 120 2005 237 248
115. S.Y. Lunt, and M.G. Vander Heiden Aerobic glycolysis: meeting the metabolic requirements of cell proliferation Annu. Rev. Cell Dev. Biol. 27 2011 441 464
116. W.W. Ma, H. Jacene, D. Song, F. Vilardell, W.A. Messersmith, D. Laheru, R. Wahl, C. Endres, A. Jimeno, M.G. Pomper, and M. Hidalgo [18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapy J. Clin. Oncol. 27 2009 2697 2704
117. M.J. MacDonald, T.F. Warner, and R.J. Mertz High activity of mitochondrial glycerol phosphate dehydrogenase in insulinomas and carcinoid and other tumors of the amine precursor uptake decarboxylation system Cancer Res. 50 1990 7203 7205
118. E.D. MacKenzie, M.A. Selak, D.A. Tennant, L.J. Payne, S. Crosby, C.M. Frederiksen, D.G. Watson, and E. Gottlieb Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells Mol. Cell. Biol. 27 2007 3282 3289
119. O.D. Maddocks, C.R. Berkers, S.M. Mason, L. Zheng, K. Blyth, E. Gottlieb, and K.H. Vousden Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells Nature 493 2013 542 546
120. E.A. Maher, I. Marin-Valencia, R.M. Bachoo, T. Mashimo, J. Raisanen, K.J. Hatanpaa, A. Jindal, F.M. Jeffrey, C. Choi, C. Madden, and et al. Metabolism of [U-13 C]glucose in human brain tumors in vivo NMR Biomed. 25 2012 1234 1244
121. S. Mannava, V. Grachtchouk, L.J. Wheeler, M. Im, D. Zhuang, E.G. Slavina, C.K. Mathews, D.S. Shewach, and M.A. Nikiforov Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells Cell Cycle 7 2008 2392 2400
122. E.R. Mardis, L. Ding, D.J. Dooling, D.E. Larson, M.D. McLellan, K. Chen, D.C. Koboldt, R.S. Fulton, K.D. Delehaunty, S.D. McGrath, and et al. Recurring mutations found by sequencing an acute myeloid leukemia genome N. Engl. J. Med. 361 2009 1058 1066
123. I. Marin-Valencia, C. Yang, T. Mashimo, S. Cho, H. Baek, X.L. Yang, K.N. Rajagopalan, M. Maddie, V. Vemireddy, Z. Zhao, and et al. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo Cell Metab. 15 2012 827 837
124. J. Márquez, F. Sánchez-Jiménez, M.A. Medina, A.R. Quesada, and I. Núñez de Castro Nitrogen metabolism in tumor bearing mice Arch. Biochem. Biophys. 268 1989 667 675
125. R. Martínez-Zaguilán, E.A. Seftor, R.E. Seftor, Y.W. Chu, R.J. Gillies, and M.J. Hendrix Acidic pH enhances the invasive behavior of human melanoma cells Clin. Exp. Metastasis 14 1996 176 186
126. T. Mashimo, K. Pichumani, V. Vemireddy, K.J. Hatanpaa, D.K. Singh, S. Sirasanagandla, S. Nannepaga, S.G. Piccirillo, Z. Kovacs, C. Foong, and et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases Cell 159 2014 1603 1614
127. J.A. McAlpine, H.T. Lu, K.C. Wu, S.K. Knowles, and J.A. Thomson Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy BMC Cancer 14 2014 621
128. M.G. Mehedint, M.D. Niculescu, C.N. Craciunescu, and S.H. Zeisel Choline deficiency alters global histone methylation and epigenetic marking at the Re1 site of the calbindin 1 gene FASEB J. 24 2010 184 195
129. J.A. Menendez, and R. Lupu Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat. Rev. Cancer 7 2007 763 777
130. C.M. Metallo, P.A. Gameiro, E.L. Bell, K.R. Mattaini, J. Yang, K. Hiller, C.M. Jewell, Z.R. Johnson, D.J. Irvine, L. Guarente, and et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia Nature 481 2012 380 384
131. T. Migita, T. Narita, K. Nomura, E. Miyagi, F. Inazuka, M. Matsuura, M. Ushijima, T. Mashima, H. Seimiya, Y. Satoh, and et al. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer Cancer Res. 68 2008 8547 8554
132. L.Z. Milgraum, L.A. Witters, G.R. Pasternack, and F.P. Kuhajda Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma Clin. Cancer Res. 3 1997 2115 2120
133. E.A. Minor, B.L. Court, J.I. Young, and G. Wang Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine J. Biol. Chem. 288 2013 13669 13674
134. R. Morais, K. Zinkewich-Péotti, M. Parent, H. Wang, F. Babai, and M. Zollinger Tumor-forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA Cancer Res. 54 1994 3889 3896
135. D.H. Munn, and A.L. Mellor Indoleamine 2,3-dioxygenase and tumor-induced tolerance J. Clin. Invest. 117 2007 1147 1154
136. T. Murakami, T. Nishiyama, T. Shirotani, Y. Shinohara, M. Kan, K. Ishii, F. Kanai, S. Nakazuru, and Y. Ebina Identification of two enhancer elements in the gene encoding the type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes J. Biol. Chem. 267 1992 9300 9306
137. L.J. Nicholson, P.R. Smith, L. Hiller, P.W. Szlosarek, C. Kimberley, J. Sehouli, D. Koensgen, A. Mustea, P. Schmid, and T. Crook Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer Int. J. Cancer 125 2009 1454 1463
138. P. Nicklin, P. Bergman, B. Zhang, E. Triantafellow, H. Wang, B. Nyfeler, H. Yang, M. Hild, C. Kung, C. Wilson, and et al. Bidirectional transport of amino acids regulates mTOR and autophagy Cell 136 2009 521 534
139. M.D. Niculescu, C.N. Craciunescu, and S.H. Zeisel Dietary choline deficiency alters global and gene-specific DNA methylation in the developing hippocampus of mouse fetal brains FASEB J. 20 2006 43 49
140. K.M. Nieman, H.A. Kenny, C.V. Penicka, A. Ladanyi, R. Buell-Gutbrod, M.R. Zillhardt, I.L. Romero, M.S. Carey, G.B. Mills, G.S. Hotamisligil, and et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth Nat. Med. 17 2011 1498 1503
141. R. Nilsson, M. Jain, N. Madhusudhan, N.G. Sheppard, L. Strittmatter, C. Kampf, J. Huang, A. Asplund, and V.K. Mootha Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer Nat. Commun. 5 2014 3128
142. E. Noch, and K. Khalili Oncogenic viruses and tumor glucose metabolism: like kids in a candy store Mol. Cancer Ther. 11 2012 14 23
143. T. Noguchi, H. Inoue, and T. Tanaka The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing J. Biol. Chem. 261 1986 13807 13812
144. D.K. Nomura, J.Z. Long, S. Niessen, H.S. Hoover, S.W. Ng, and B.F. Cravatt Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis Cell 140 2010 49 61
145. W.M. Oldham, C.B. Clish, Y. Yang, and J. Loscalzo Hypoxia-mediated increases in l-2-hydroxyglutarate coordinate the metabolic response to reductive stress Cell Metab. 22 2015 291 303
146. C.A. Opitz, U.M. Litzenburger, F. Sahm, M. Ott, I. Tritschler, S. Trump, T. Schumacher, L. Jestaedt, D. Schrenk, M. Weller, and et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor Nature 478 2011 197 203
147. T. Osada, I. Nagashima, N.H. Tsuno, J. Kitayama, and H. Nagawa Prognostic significance of glutamine synthetase expression in unifocal advanced hepatocellular carcinoma J. Hepatol. 33 2000 247 253
148. W. Palm, Y. Park, K. Wright, N.N. Pavlova, D.A. Tuveson, and C.B. Thompson The utilization of extracellular proteins as nutrients is suppressed by mTORC1 Cell 162 2015 259 270
149. I. Papandreou, R.A. Cairns, L. Fontana, A.L. Lim, and N.C. Denko HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption Cell Metab. 3 2006 187 197
150. D.W. Parsons, S. Jones, X. Zhang, J.C. Lin, R.J. Leary, P. Angenendt, P. Mankoo, H. Carter, I.M. Siu, G.L. Gallia, and et al. An integrated genomic analysis of human glioblastoma multiforme Science 321 2008 1807 1812
151. P. Paschka, R.F. Schlenk, V.I. Gaidzik, M. Habdank, J. Krönke, L. Bullinger, D. Späth, S. Kayser, M. Zucknick, K. Götze, and et al. IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication J. Clin. Oncol. 28 2010 3636 3643
152. K.T. Pate, C. Stringari, S. Sprowl-Tanio, K. Wang, T. TeSlaa, N.P. Hoverter, M.M. McQuade, C. Garner, M.A. Digman, M.A. Teitell, and et al. Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer EMBO J. 33 2014 1454 1473
153. J.M. Phang, S.P. Donald, J. Pandhare, and Y. Liu The metabolism of proline, a stress substrate, modulates carcinogenic pathways Amino Acids 35 2008 681 690
154. R. Pieters, S.P. Hunger, J. Boos, C. Rizzari, L. Silverman, A. Baruchel, N. Goekbuget, M. Schrappe, and C.H. Pui L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase Cancer 117 2011 238 249
155. D.R. Plas, S. Talapatra, A.L. Edinger, J.C. Rathmell, and C.B. Thompson Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology J. Biol. Chem. 276 2001 12041 12048
156. R. Possemato, K.M. Marks, Y.D. Shaul, M.E. Pacold, D. Kim, K. Birsoy, S. Sethumadhavan, H.K. Woo, H.G. Jang, A.K. Jha, and et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer Nature 476 2011 346 350
157. J.C. Rathmell, M.G. Vander Heiden, M.H. Harris, K.A. Frauwirth, and C.B. Thompson In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability Mol. Cell 6 2000 683 692
158. J.C. Rathmell, C.J. Fox, D.R. Plas, P.S. Hammerman, R.M. Cinalli, and C.B. Thompson Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival Mol. Cell. Biol. 23 2003 7315 7328
159. M.R. Reynolds, A.N. Lane, B. Robertson, S. Kemp, Y. Liu, B.G. Hill, D.C. Dean, and B.F. Clem Control of glutamine metabolism by the tumor suppressor Rb Oncogene 33 2014 556 566
160. E.L. Richman, S.A. Kenfield, M.J. Stampfer, E.L. Giovannucci, S.H. Zeisel, W.C. Willett, and J.M. Chan Choline intake and risk of lethal prostate cancer: incidence and survival Am. J. Clin. Nutr. 96 2012 855 863
161. S. Rivera, J. Azcón-Bieto, F.J. López-Soriano, M. Miralpeix, and J.M. Argilés Amino acid metabolism in tumour-bearing mice Biochem. J. 249 1988 443 449
162. E. Roberts, and S. Frankel Free amino acids in normal and neoplastic tissues of mice as studied by paper chromatography Cancer Res. 9 1949 645 648 643 pl
163. A.M. Robitaille, S. Christen, M. Shimobayashi, M. Cornu, L.L. Fava, S. Moes, C. Prescianotto-Baschong, U. Sauer, P. Jenoe, and M.N. Hall Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis Science 339 2013 1320 1323
164. D. Rohle, J. Popovici-Muller, N. Palaskas, S. Turcan, C. Grommes, C. Campos, J. Tsoi, O. Clark, B. Oldrini, E. Komisopoulou, and et al. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells Science 340 2013 626 630
165. J.M. Rothberg, K.M. Bailey, J.W. Wojtkowiak, Y. Ben-Nun, M. Bogyo, E. Weber, K. Moin, G. Blum, R.R. Mattingly, R.J. Gillies, and B.F. Sloane Acid-mediated tumor proteolysis: contribution of cysteine cathepsins Neoplasia 15 2013 1125 1137
166. E. Rysman, K. Brusselmans, K. Scheys, L. Timmermans, R. Derua, S. Munck, P.P. Van Veldhoven, D. Waltregny, V.W. Daniëls, J. Machiels, and et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation Cancer Res. 70 2010 8117 8126
167. B.R. Sabari, Z. Tang, H. Huang, V. Yong-Gonzalez, H. Molina, H.E. Kong, L. Dai, M. Shimada, J.R. Cross, Y. Zhao, and et al. Intracellular crotonyl-CoA stimulates transcription through p300-catalyzed histone crotonylation Mol. Cell 58 2015 203 215
168. M. Sasaki, C.B. Knobbe, J.C. Munger, E.F. Lind, D. Brenner, A. Brüstle, I.S. Harris, R. Holmes, A. Wakeham, J. Haight, and et al. IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics Nature 488 2012 656 659
169. L.A. Sauer, J.W. Stayman 3rd, and R.T. Dauchy Amino acid, glucose, and lactic acid utilization in vivo by rat tumors Cancer Res. 42 1982 4090 4097
170. Z.T. Schafer, A.R. Grassian, L. Song, Z. Jiang, Z. Gerhart-Hines, H.Y. Irie, S. Gao, P. Puigserver, and J.S. Brugge Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment Nature 461 2009 109 113
171. S.A. Schmid, A. Gaumann, M. Wondrak, C. Eckermann, S. Schulte, W. Mueller-Klieser, D.N. Wheatley, and L.A. Kunz-Schughart Lactate adversely affects the in vitro formation of endothelial cell tubular structures through the action of TGF-beta1 Exp. Cell Res. 313 2007 2531 2549
172. Z.T. Schug, B. Peck, D.T. Jones, Q. Zhang, S. Grosskurth, I.S. Alam, L.M. Goodwin, E. Smethurst, S. Mason, K. Blyth, and et al. Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress Cancer Cell 27 2015 57 71
173. B. Schwer, and E. Verdin Conserved metabolic regulatory functions of sirtuins Cell Metab. 7 2008 104 112
174. M.A. Selak, S.M. Armour, E.D. MacKenzie, H. Boulahbel, D.G. Watson, K.D. Mansfield, Y. Pan, M.C. Simon, C.B. Thompson, and E. Gottlieb Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase Cancer Cell 7 2005 77 85
175. K. Sellers, M.P. Fox, M. Bousamra 2nd, S.P. Slone, R.M. Higashi, D.M. Miller, Y. Wang, J. Yan, M.O. Yuneva, R. Deshpande, and et al. Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation J. Clin. Invest. 125 2015 687 698
176. L. Shi, and B.P. Tu Acetyl-CoA induces transcription of the key G1 cyclin CLN3 to promote entry into the cell division cycle in Saccharomyces cerevisiae Proc. Natl. Acad. Sci. USA 110 2013 7318 7323
177. Y. Shi, F. Lan, C. Matson, P. Mulligan, J.R. Whetstine, P.A. Cole, R.A. Casero, and Y. Shi Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 Cell 119 2004 941 953
178. E.H. Shim, C.B. Livi, D. Rakheja, J. Tan, D. Benson, V. Parekh, E.Y. Kho, A.P. Ghosh, R. Kirkman, S. Velu, and et al. L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer Cancer Discov. 4 2014 1290 1298
179. N. Shyh-Chang, J.W. Locasale, C.A. Lyssiotis, Y. Zheng, R.Y. Teo, S. Ratanasirintrawoot, J. Zhang, T. Onder, J.J. Unternaehrer, H. Zhu, and et al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation Science 339 2013 222 226
180. K. Sircar, H. Huang, L. Hu, D. Cogdell, J. Dhillon, V. Tzelepi, E. Efstathiou, I.H. Koumakpayi, F. Saad, D. Luo, and et al. Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer Am. J. Pathol. 180 2012 895 903
181. P. Som, H.L. Atkins, D. Bandoypadhyay, J.S. Fowler, R.R. MacGregor, K. Matsui, Z.H. Oster, D.F. Sacker, C.Y. Shiue, H. Turner, and et al. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection J. Nucl. Med. 21 1980 670 675
182. J. Son, C.A. Lyssiotis, H. Ying, X. Wang, S. Hua, M. Ligorio, R.M. Perera, C.R. Ferrone, E. Mullarky, N. Shyh-Chang, and et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway Nature 496 2013 101 105
183. P. Sonveaux, T. Copetti, C.J. De Saedeleer, F. Végran, J. Verrax, K.M. Kennedy, E.J. Moon, S. Dhup, P. Danhier, F. Frérart, and et al. Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis PLoS ONE 7 2012 e33418
184. R.G. Spiro Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds Glycobiology 12 2002 43R 56R
185. M.B. Sporn, and K.T. Liby NRF2 and cancer: the good, the bad and the importance of context Nat. Rev. Cancer 12 2012 564 571
186. R. Stern, S. Shuster, B.A. Neudecker, and B. Formby Lactate stimulates fibroblast expression of hyaluronan and CD44: the Warburg effect revisited Exp. Cell Res. 276 2002 24 31
187. A. Stolzing, and T. Grune Neuronal apoptotic bodies: phagocytosis and degradation by primary microglial cells FASEB J. 18 2004 743 745
188. A.M. Strohecker, J.Y. Guo, G. Karsli-Uzunbas, S.M. Price, G.J. Chen, R. Mathew, M. McMahon, and E. White Autophagy sustains mitochondrial glutamine metabolism and growth of BrafV600E-driven lung tumors Cancer Discov. 3 2013 1272 1285
189. L.B. Sullivan, and N.S. Chandel Mitochondrial reactive oxygen species and cancer Cancer Metab. 2 2014 17
190. L.B. Sullivan, D.Y. Gui, A.M. Hosios, L.N. Bush, E. Freinkman, and M.G. Vander Heiden Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells Cell 162 2015 552 563
191. Q. Sun, T. Luo, Y. Ren, O. Florey, S. Shirasawa, T. Sasazuki, D.N. Robinson, and M. Overholtzer Competition between human cells by entosis Cell Res. 24 2014 1299 1310
192. E. Svastová, A. Hulíková, M. Rafajová, M. Zat'ovicová, A. Gibadulinová, A. Casini, A. Cecchi, A. Scozzafava, C.T. Supuran, J. Pastorek, and S. Pastoreková Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH FEBS Lett. 577 2004 439 445
193. P. Swietach, R.D. Vaughan-Jones, and A.L. Harris Regulation of tumor pH and the role of carbonic anhydrase 9 Cancer Metastasis Rev. 26 2007 299 310
194. A.S. Tan, J.W. Baty, L.F. Dong, A. Bezawork-Geleta, B. Endaya, J. Goodwin, M. Bajzikova, J. Kovarova, M. Peterka, B. Yan, and et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA Cell Metab. 21 2015 81 94
195. A. Terunuma, N. Putluri, P. Mishra, E.A. Mathé, T.H. Dorsey, M. Yi, T.A. Wallace, H.J. Issaq, M. Zhou, J.K. Killian, and et al. MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis J. Clin. Invest. 124 2014 398 412
196. C.B. Thompson Rethinking the regulation of cellular metabolism Cold Spring Harb. Symp. Quant. Biol. 76 2011 23 29
197. A.S. Tibbetts, and D.R. Appling Compartmentalization of Mammalian folate-mediated one-carbon metabolism Annu. Rev. Nutr. 30 2010 57 81
198. I.P. Tomlinson, N.A. Alam, A.J. Rowan, E. Barclay, E.E. Jaeger, D. Kelsell, I. Leigh, P. Gorman, H. Lamlum, S. Rahman, et al. Multiple Leiomyoma Consortium Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer Nat. Genet. 30 2002 406 410
199. B.D. Towbin, C. González-Aguilera, R. Sack, D. Gaidatzis, V. Kalck, P. Meister, P. Askjaer, and S.M. Gasser Step-wise methylation of histone H3K9 positions heterochromatin at the nuclear periphery Cell 150 2012 934 947
200. S. Turcan, D. Rohle, A. Goenka, L.A. Walsh, F. Fang, E. Yilmaz, C. Campos, A.W. Fabius, C. Lu, P.S. Ward, and et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype Nature 483 2012 479 483
201. E. Vacchelli, F. Aranda, A. Eggermont, C. Sautès-Fridman, E. Tartour, E.P. Kennedy, M. Platten, L. Zitvogel, G. Kroemer, and L. Galluzzi Trial watch: IDO inhibitors in cancer therapy OncoImmunology 3 2014 e957994
202. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 2009 1029 1033
203. P. Vaupel, F. Kallinowski, and P. Okunieff Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review Cancer Res. 49 1989 6449 6465
204. F. Végran, R. Boidot, C. Michiels, P. Sonveaux, and O. Feron Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis Cancer Res. 71 2011 2550 2560
205. S. Venneti, M.P. Dunphy, H. Zhang, K.L. Pitter, P. Zanzonico, C. Campos, S.D. Carlin, G. La Rocca, S. Lyashchenko, K. Ploessl, and et al. Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo Sci. Transl. Med. 7 2015 274ra17
206. A. Viale, P. Pettazzoni, C.A. Lyssiotis, H. Ying, N. Sánchez, M. Marchesini, A. Carugo, T. Green, S. Seth, V. Giuliani, and et al. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function Nature 514 2014 628 632
207. B. Vogelstein, and K.W. Kinzler Cancer genes and the pathways they control Nat. Med. 10 2004 789 799
208. T. Wahlström, and M.A. Henriksson Impact of MYC in regulation of tumor cell metabolism Biochim. Biophys. Acta 1849 2015 563 569
209. C. Wang, K. Guo, D. Gao, X. Kang, K. Jiang, Y. Li, L. Sun, S. Zhang, C. Sun, X. Liu, and et al. Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples Cancer Lett. 313 2011 154 166
210. R. Wang, C.P. Dillon, L.Z. Shi, S. Milasta, R. Carter, D. Finkelstein, L.L. McCormick, P. Fitzgerald, H. Chi, J. Munger, and D.R. Green The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation Immunity 35 2011 871 882
211. F. Wang, J. Travins, B. DeLaBarre, V. Penard-Lacronique, S. Schalm, E. Hansen, K. Straley, A. Kernytsky, W. Liu, C. Gliser, and et al. Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation Science 340 2013 622 626
212. O. Warburg On the origin of cancer cells Science 123 1956 309 314
213. O.P.K. Warburg, and E. Negelein Über den Stoffwechsel der Carcinomzelle Biochem Zeitschr 152 1924 309 344
214. O. Warburg, F. Wind, and E. Negelein The metabolism of tumors in the body J. Gen. Physiol. 8 1927 519 530
215. P.S. Ward, J. Patel, D.R. Wise, O. Abdel-Wahab, B.D. Bennett, H.A. Coller, J.R. Cross, V.R. Fantin, C.V. Hedvat, A.E. Perl, and et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate Cancer Cell 17 2010 225 234
216. K.E. Wellen, G. Hatzivassiliou, U.M. Sachdeva, T.V. Bui, J.R. Cross, and C.B. Thompson ATP-citrate lyase links cellular metabolism to histone acetylation Science 324 2009 1076 1080
217. K.E. Wellen, C. Lu, A. Mancuso, J.M. Lemons, M. Ryczko, J.W. Dennis, J.D. Rabinowitz, H.A. Coller, and C.B. Thompson The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism Genes Dev. 24 2010 2784 2799
218. H.L. Wieman, J.A. Wofford, and J.C. Rathmell Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking Mol. Biol. Cell 18 2007 1437 1446
219. D.R. Wise, R.J. DeBerardinis, A. Mancuso, N. Sayed, X.Y. Zhang, H.K. Pfeiffer, I. Nissim, E. Daikhin, M. Yudkoff, S.B. McMahon, and C.B. Thompson Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction Proc. Natl. Acad. Sci. USA 105 2008 18782 18787
220. D.R. Wise, P.S. Ward, J.E. Shay, J.R. Cross, J.J. Gruber, U.M. Sachdeva, J.M. Platt, R.G. DeMatteo, M.C. Simon, and C.B. Thompson Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability Proc. Natl. Acad. Sci. USA 108 2011 19611 19616
221. J.R. Wisniewski, A. Zougman, and M. Mann Nepsilon-formylation of lysine is a widespread post-translational modification of nuclear proteins occurring at residues involved in regulation of chromatin function Nucleic Acids Res. 36 2008 570 577
222. D. Wu, W. Si, M. Wang, S. Lv, A. Ji, and Y. Li Hydrogen sulfide in cancer: friend or foe? Nitric Oxide 50 2015 38 45
223. M. Xiao, H. Yang, W. Xu, S. Ma, H. Lin, H. Zhu, L. Liu, Y. Liu, C. Yang, Y. Xu, and et al. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors Genes Dev. 26 2012 1326 1338
224. Z. Xie, J. Dai, L. Dai, M. Tan, Z. Cheng, Y. Wu, J.D. Boeke, and Y. Zhao Lysine succinylation and lysine malonylation in histones Mol. Cell. Proteomics 11 2012 100 107
225. X. Xu, M.D. Gammon, S.H. Zeisel, P.T. Bradshaw, J.G. Wetmur, S.L. Teitelbaum, A.I. Neugut, R.M. Santella, and J. Chen High intakes of choline and betaine reduce breast cancer mortality in a population-based study FASEB J. 23 2009 4022 4028
226. X. Xu, A. Zur Hausen, J.F. Coy, and M. Löchelt Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells Int. J. Cancer 124 2009 1330 1337
227. W. Xu, H. Yang, Y. Liu, Y. Yang, P. Wang, S.H. Kim, S. Ito, C. Yang, P. Wang, M.T. Xiao, and et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases Cancer Cell 19 2011 17 30
228. S.R. Yan, and G. Berton Regulation of Src family tyrosine kinase activities in adherent human neutrophils. Evidence that reactive oxygen intermediates produced by adherent neutrophils increase the activity of the p58c-fgr and p53/56lyn tyrosine kinases J. Biol. Chem. 271 1996 23464 23471
229. O. Yanagida, Y. Kanai, A. Chairoungdua, D.K. Kim, H. Segawa, T. Nii, S.H. Cha, H. Matsuo, J. Fukushima, Y. Fukasawa, and et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines Biochim. Biophys. Acta 1514 2001 291 302
230. J. Ye, A. Mancuso, X. Tong, P.S. Ward, J. Fan, J.D. Rabinowitz, and C.B. Thompson Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation Proc. Natl. Acad. Sci. USA 109 2012 6904 6909
231. J. Ye, J. Fan, S. Venneti, Y.W. Wan, B.R. Pawel, J. Zhang, L.W. Finley, C. Lu, T. Lindsten, J.R. Cross, and et al. Serine catabolism regulates mitochondrial redox control during hypoxia Cancer Discov. 4 2014 1406 1417
232. H. Ying, A.C. Kimmelman, C.A. Lyssiotis, S. Hua, G.C. Chu, E. Fletcher-Sananikone, J.W. Locasale, J. Son, H. Zhang, J.L. Coloff, and et al. Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism Cell 149 2012 656 670
233. J. Ying, M.H. Rahbar, D.M. Hallman, L.M. Hernandez, M.R. Spitz, M.R. Forman, and O.Y. Gorlova Associations between dietary intake of choline and betaine and lung cancer risk PLoS ONE 8 2013 e54561
234. C.Y. Yoon, Y.J. Shim, E.H. Kim, J.H. Lee, N.H. Won, J.H. Kim, I.S. Park, D.K. Yoon, and B.H. Min Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase Int. J. Cancer 120 2007 897 905
235. R.M. Young, D. Ackerman, Z.L. Quinn, A. Mancuso, M. Gruber, L. Liu, D.N. Giannoukos, E. Bobrovnikova-Marjon, J.A. Diehl, B. Keith, and M.C. Simon Dysregulated mTORC1 renders cells critically dependent on desaturated lipids for survival under tumor-like stress Genes Dev. 27 2013 1115 1131
236. M. Yuneva, N. Zamboni, P. Oefner, R. Sachidanandam, and Y. Lazebnik Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells J. Cell Biol. 178 2007 93 105
237. M.O. Yuneva, T.W. Fan, T.D. Allen, R.M. Higashi, D.V. Ferraris, T. Tsukamoto, J.M. Matés, F.J. Alonso, C. Wang, Y. Seo, and et al. The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type Cell Metab. 15 2012 157 170
238. C.X. Zhang, M.X. Pan, B. Li, L. Wang, X.F. Mo, Y.M. Chen, F.Y. Lin, and S.C. Ho Choline and betaine intake is inversely associated with breast cancer risk: a two-stage case-control study in China Cancer Sci. 104 2013 250 258
239. J. Zhang, J. Fan, S. Venneti, J.R. Cross, T. Takagi, B. Bhinder, H. Djaballah, M. Kanai, E.H. Cheng, A.R. Judkins, and et al. Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion Mol. Cell 56 2014 205 218